Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/13/25 17:05 | 6/11/25 | CALC | Health | Drug | Pharmaceutical Preparations | Roberts Eric W | CA | DOT | CHIEF BU | 8 | P.m | 305 | 3.37 | 0 | 90 | 10 | 993 | I | ||||||||||||||
6/3/25 17:10 | 5/30/25 | CALC | Health | Drug | Pharmaceutical Preparations | Bardin Stephen | CA | O | CFO | 1 | P | 2 | 1.69 | 0 | 1 | 3 | 41 | D | ||||||||||||||
12/6/24 19:12 | 12/6/24 | CALC | Health | Drug | Pharmaceutical Preparations | Middleton Fred A | CA | DT | 2 | P | 417 | 3.70 | 0 | 113 | 5 | 2,452 | D | |||||||||||||||
11/5/24 15:08 | 11/1/24 | CALC | Health | Drug | Pharmaceutical Preparations | Sanderling Venture Partners VI Co Investment Fund LP | CA | T | 1 | P | 329 | 3.75 | 0 | 88 | 4 | 2,407 | M | |||||||||||||||
11/1/24 13:25 | 11/1/24 | CALC | Health | Drug | Pharmaceutical Preparations | Leheny A. Rachel | CA | DOT | CEO | 2 | P | 79 | 3.77 | 0 | 21 | 2 | 871 | D | ||||||||||||||
11/1/24 13:22 | 11/1/24 | CALC | Health | Drug | Pharmaceutical Preparations | Wilson Robert N | CA | D | 4 | P | 609 | 3.64 | 0 | 167 | 67 | 418 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |